QA: Biodelivery Sciences International INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001103021_2014_Biodelivery_Sciences_International_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001103021, Biodelivery Sciences International INC

  xvar xval
0 AssetsCurrent 26,600,506
1 IntangibleAssetsNetIncludingGoodwill 7,911,498
2 PropertyPlantAndEquipmentNet 178,168
3 remainder_Assets 3,315,253
4 LiabilitiesCurrent 24,991,585
5 LiabilitiesNoncurrent 700,000
6 remainder_Liabilities 13,126,191
7 CostOfGoodsAndServicesSold 2,082,183
8 SellingGeneralAndAdministrativeExpense 12,302,364
9 ResearchAndDevelopmentExpense 53,326,777
10 remainder_Expenses 46,500
11 remainder_Revenues 11,355,883
12 remainder_NetIncome -991,672
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,005,425
1 Liabilities 38,817,776
2 Expenses 67,757,824
3 Revenues 11,355,883
4 StockholdersEquity -812,351
5 NetIncome -57,393,613
6 ComprehensiveNetIncome -57,393,613
7 BaseVar 78,464,290
8 EconomicCapitalRatiobeforeLimitedLiability -1.54
9 EconomicCapitalRatio 1.17

Edgar->Model Mapping

Feature Distribution

Change over Time